← Back to directory
AV
AN Venture Partners
Tokyo, Japan; San Francisco, United StatesWebsite ↗
AN Venture Partners (ANV) is a Tokyo and San Francisco-based multi-stage, global biotech venture capital firm specializing in bridging innovative science from Japan with the US start-up ecosystem. The firm was founded in 2022 with the goal of strengthening Japan's biotech ecosystem.
Last raised
Jun 2025
1y 2mo ago
Latest fund size
$200M
AN Venture Partners I, LP
AUM
$200M
estimated
Funds raised
Capital this firm has raised, newest first
AN Venture Partners I, LP
Jun 2025 · Fund I
$200M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| PAhR Therapeutics | — | — | Unknown | |
| Tortugas Neuroscience | Series A | $106M | Unknown | |
| Crystalys Therapeutics | Series A | $205M | Sep 2025 | |
| Imbria Pharmaceuticals | Series B | $57.5M | Apr 2025 | |
| City Therapeutics | Series A | $135M | Oct 2024 | |
| Typewriter Therapeutics | — | — | Feb 2024 | |
| Capacity Bio | — | — | Mar 2023 |
Sources
Where this data came from